Oncogenic NRAS Cooperates with p53 Loss to Generate Melanoma in Zebrafish

被引:102
作者
Dovey, Michael
White, Richard Mark
Zon, Leonard I. [1 ]
机构
[1] Childrens Hosp, Stem Cell Program & Hematol Oncol, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
MALIGNANT-MELANOMA; TUMOR PROGRESSION; BRAF MUTATIONS; RAS MUTATIONS; N-RAS; MELANOCYTIC LESIONS; SENESCENCE; EXPRESSION; NEVI; SUSCEPTIBILITY;
D O I
10.1089/zeb.2009.0606
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
NRAS mutations are a common oncogenic event in skin cancer, occurring frequently in congenital nevi and malignant melanoma. To study the role of NRAS in zebrafish, a transgenic approach was applied to generate fish that express human oncogenic NRAS(Q61K) under the control of the melanocyte-restricted mitfa promoter. By screening the progeny of the injected animals, two strains stably expressing the NRAS transgene were identified: Tg(mitfa:EGFP:NRAS(Q61K))(1) and Tg(mitfa:EGFP:NRAS(Q61K))(2). Stable expression of this transgene results in hyperpigmented fish displaying a complete ablation of the normal pigment pattern. Although oncogenic NRAS expression alone was found to be insufficient to promote tumor formation, loss of functional p53 was found to collaborate with NRAS expression in the genesis of melanoma. The tumors derived from these animals are variably pigmented and closely resemble human melanoma. Underscoring the pathological similarities between these tumors and human disease and suggesting that common pathways are similar in these models and human disease, gene set enrichment analysis performed on microarray data found that the upregulated genes from zebrafish melanomas are highly enriched in human tumor samples. This work characterizes two zebrafish melanoma models that will be useful tools for the study of melanoma pathogenesis.
引用
收藏
页码:397 / 404
页数:8
相关论文
共 28 条
[1]   Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background [J].
Ackermann, J ;
Frutschi, M ;
Kaloulis, K ;
McKee, T ;
Trumpp, A ;
Beermann, F .
CANCER RESEARCH, 2005, 65 (10) :4005-4011
[2]  
ALBINO AP, 1989, ONCOGENE, V4, P1363
[3]   Real-time quantitative PCR-based system for determining transgene copy number in transgenic animals [J].
Ballester, M ;
Castelló, A ;
Ibáñez, E ;
Sánchez, A ;
Folch, JM .
BIOTECHNIQUES, 2004, 37 (04) :610-613
[4]  
BOS JL, 1989, CANCER RES, V49, P4682
[5]   Cooperative effects of INK4a and ras in melanoma susceptibility in vivo [J].
Chin, L ;
Pomerantz, J ;
Polsky, D ;
Jacobson, M ;
Cohen, C ;
CordonCardo, C ;
Horner, JW ;
DePinho, RA .
GENES & DEVELOPMENT, 1997, 11 (21) :2822-2834
[6]   Malignant melanoma: genetics and therapeutics in the genomic era [J].
Chin, Lynda ;
Garraway, Levi A. ;
Fisher, David E. .
GENES & DEVELOPMENT, 2006, 20 (16) :2149-2182
[7]   Endomembrane trafficking of Ras: The CAAX motif targets proteins to the ER and Golgi [J].
Choy, E ;
Chiu, VK ;
Silletti, J ;
Feoktistov, M ;
Morimoto, T ;
Michaelson, D ;
Ivanov, IE ;
Philips, MR .
CELL, 1999, 98 (01) :69-80
[8]   Use of human tissue to assess the oncogenic activity of melanoma-associated mutations [J].
Chudnovsky, Y ;
Adams, AE ;
Robbins, PB ;
Lin, Q ;
Khavari, PA .
NATURE GENETICS, 2005, 37 (07) :745-749
[9]   Analysis of N- and K-ras mutations in the distinctive tumor progression phases of melanoma [J].
Demunter, A ;
Stas, M ;
Degreef, H ;
De Wolf-Peeters, C ;
van den Oord, JJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (06) :1483-1489
[10]   High intensity ras signaling induces premature senescence by activating p38 pathway in primary human fibroblasts [J].
Deng, QD ;
Liao, R ;
Wu, BL ;
Sun, PQ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (02) :1050-1059